IHWM
UTHR icon

Iron Horse Wealth Management’s United Therapeutics UTHR Stock Holding History

Iron Horse Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$4.31K Hold
15
– – ﹤0.01% 397
2025
Q1 		$4.62K Hold
15
– – ﹤0.01% 371
2024
Q4 		$5.29K Hold
15
– – ﹤0.01% 299
2024
Q3 		$5.38K Hold
15
– – ﹤0.01% 295
2024
Q2 		$4.78K Hold
15
– – ﹤0.01% 281
2024
Q1 		$3.45K Hold
15
– – ﹤0.01% 288
2023
Q4 		$3.3K Hold
15
– – ﹤0.01% 307
2023
Q3 		$3.39K Buy
+15
New +$3.46K ﹤0.01% 303

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Iron Horse Wealth Management's UTHR Position: Q2 2025 in Review

Iron Horse Wealth Management held its United Therapeutics (UTHR) position steady in Q2 2025 at 15 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Iron Horse Wealth Management first reported a position in UTHR in Q3 2023 and has held it in 8 quarters since. The position peaked at $5.38K in Q3 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • Iron Horse Wealth Management held 15 shares of United Therapeutics worth $4.31K as of Q2 2025.
  • Iron Horse Wealth Management left its United Therapeutics share count unchanged in Q2 2025.
  • United Therapeutics made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #397 holding.
  • Iron Horse Wealth Management first reported a position in United Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • Iron Horse Wealth Management's United Therapeutics position peaked at $5.38K in Q3 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.